BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025)
BioNTech SE (BNTX) posted Exchange Rate Effect of $1.6 million for Q4 2025, up 106.48% on a QoQ basis from -$25.1 million in Q3 2025, and down 88.79% year-over-year from $14.5 million in Q4 2024.
BioNTech SE (BNTX) has 8 years of Exchange Rate Effect data on file, last reported at $1.6 million in Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 88.79% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at -$30.0 million (down 289.55% YoY), while the FY2025 annual figure was -$30.5 million, down 292.88% from the prior year.
- Exchange Rate Effect grew to $1.6 million in Q4 2025, from -$25.1 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $865.0 million in Q4 2022 and bottomed at -$105.2 million in Q4 2021.
- A 5-year average of $88.0 million and a median of $4.5 million in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect sank 191894673.21% — and 2022, when it soared 1959797846.1%.
- Year by year, Exchange Rate Effect stood at -$105.2 million in 2021, then surged by 921.86% to $865.0 million in 2022, then plunged by 101.92% to -$16.6 million in 2023, then soared by 187.71% to $14.5 million in 2024, then slumped by 88.79% to $1.6 million in 2025.
- The last three Exchange Rate Effect figures came in at $1.6 million (Q4 2025), -$25.1 million (Q3 2025), and $10.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Sep 30, 2023 | 66.62 Mn |
| Sep 30, 2023 | 66.62 Mn |
| Jun 30, 2023 | 99.31 Mn |
| Jun 30, 2023 | 99.31 Mn |
| Mar 31, 2023 | -29.09 Mn |
| Mar 31, 2023 | -29.09 Mn |
| Dec 31, 2022 | 864.97 Mn |
| Dec 31, 2022 | 864.97 Mn |
| Sep 30, 2022 | 117.16 Mn |
| Sep 30, 2022 | 117.16 Mn |
| Jun 30, 2022 | 118.98 Mn |
| Jun 30, 2022 | 118.98 Mn |
| Mar 31, 2022 | 600.45 Mn |
| Mar 31, 2022 | 600.45 Mn |
| Dec 31, 2021 | -105.25 Mn |
| Dec 31, 2021 | -105.25 Mn |
| Sep 30, 2021 | 58.26 Mn |
| Sep 30, 2021 | 58.26 Mn |
| Jun 30, 2021 | -240,854.29 |
| Jun 30, 2021 | -240,854.29 |
| Mar 31, 2021 | 30.64 |
| Mar 31, 2021 | 30.64 |
| Dec 31, 2020 | -54.85 |
| Dec 31, 2020 | -54.85 |
| Mar 31, 2020 | 110,393.90 |
| Mar 31, 2020 | 110,393.90 |
| Dec 31, 2019 | -50,916.83 |
| Dec 31, 2019 | -50,916.83 |
| Dec 31, 2018 | -11,937.87 |
| Dec 31, 2018 | -11,937.87 |